1Emancipator SN, Lamm ME. IgA nephropathy : pathogensis of the most common from of glomerolonephritis. Lab Invest, 1989,60 (2) :168 -183.
2Rifai A, Small PA Jr, Teague PO, et al. Experimental IgA ne- phropathy. J Exp Med, 1979,150 (5) : 1161 - 1173.
3Isaacs K, Miller F, Lane B. Experimental model for IgA nephrop- athy. Clin lmmunol lmmunopathol, 1981,20 ( 3 ) :419 - 426.
4Pasi A, Dendorfer U, Holthtifer H, et al. Characterization of ne- phropathy induced by immunization with high molecular weight dextran. Nephrol Dial Transplant, 1997,12 ( 9 ) : 1849 - 1855.
6Kuki K, Gotoh H, Hayashi M, et al. Immunity of tonsil and IgA nephropathy -relationship between IgA nephropathy and tonsilli- tis. Acta Otolaryngol Supp1,2004 ,555 ( 1 ) :6 - 9.
8Sharmin S, Shimizu Y, Hagiwara M, et al. Staphylococcus aureus antigens induce IgA - type glomerulonephritis in Balb/c mice. J Nephro1,2004,17 (4) :504 - 511.
9Kuki K, Gotoh H, Hayashi M, et al. Immunity of tonsil and IgA nephropathy-relationship between IgA nephropathy and tonsillitis [J]. Acta Otolaryngol Suppl, 2004, 555: 6-9.
10Horie A, Hiki Y, Odani H, et al. IgA1 molecules produced by tonsillar lymphocytes are under-O-glyeosylated in IgA nephropathy [J]. Am J Kidney Dis, 2003, 42(3): 486-96.
9Berger J, Hinglais N. Intercapillary deposits of IgA - IgG. J Urol Nephrol ( Paris), 1968,74 (9) :694 - 695.
10Taylor RP,Sutherland WM,Reist CJ,et al.Using of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes:a potential therapeutic treatment.Proc Natl Acad Sci USA,1991,88(8):3305.
